Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Assembly Biosciences (ASMB) Return on Equity (2016 - 2025)

Assembly Biosciences (ASMB) has 11 years of Return on Equity data on record, last reported at 0.38% in Q3 2025.

  • For Q3 2025, Return on Equity rose 96.0% year-over-year to 0.38%; the TTM value through Sep 2025 reached 0.38%, up 96.0%, while the annual FY2024 figure was 1.08%, 9.0% down from the prior year.
  • Return on Equity reached 0.38% in Q3 2025 per ASMB's latest filing, up from 1.72% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.26% in Q1 2021 and bottomed at 1.72% in Q2 2025.
  • Average Return on Equity over 5 years is 1.06%, with a median of 1.18% recorded in 2022.
  • Peak YoY movement for Return on Equity: crashed -70bps in 2022, then skyrocketed 96bps in 2025.
  • A 5-year view of Return on Equity shows it stood at 0.67% in 2021, then plummeted by -50bps to 1.01% in 2022, then plummeted by -47bps to 1.48% in 2023, then grew by 8bps to 1.35% in 2024, then skyrocketed by 72bps to 0.38% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Equity were 0.38% in Q3 2025, 1.72% in Q2 2025, and 1.32% in Q1 2025.